goldencyclist60 said:Look, you’re clearly obsessed with digging this hole deeper. Your entire argument is exactly why these studies actually make you weaker 🙂
but I’m done here. I've finished this debate with you, and frankly, you should learn when to walk away—especially at your age.
Stop stripping things out of context, stop putting words in my mouth, and find someone else to peddle this nonsense to. Good luck at the championships. 🙂
One more thing.
There is no recovery supplement on the market with a 1:1 glucose-to-fructose ratio. Not a single nutritionist outside of your own head would ever recommend pure sucrose to an athlete for recovery. You’ve clearly forgotten how this whole conversation started. And please, stop trying to force your opinions on people and recommending pure sugar post-workout; someone might actually listen to you.
And finally, here is the copy-paste reality of your "studies":
CONCLUSIONS FROM THE OVERALL BODY OF
EVIDENCE
The purpose of this review was to use a systematic, evidence-based
approach to determine if a causal relationship exists between
ingestion of fructose in a normal, dietary manner and
the development of alterations in lipid and/or carbohydrate
metabolism and increases in body weight in overweight or obese
humans. Studies investigating the effect of sugar on blood
lipids, glucose, insulin, obesity, or body weight of overweight
or obese humans were identified by literature searches, obtained
and reviewed. All studies that used levels of sugar consumption
greater than the estimated 95th percentile (± SE) intake
levels were excluded from the analysis. The remaining studies
were graded according to a scale developed by the authors, based
on guidance provided by FDA for evaluation of health claims.
Although the majority of the studies were considered to be of
moderate quality, the database is considered to be sufficient for
the assessment.
The results of the majority of the short-term studies involving
overweight or obese subjects show that in the short-term (i.e.
up to approximately three hours after consumption), ingestion
of 30–100 g/day fructose is associated with either no change or
a slight increase in serum TG and decreases in plasma insulin
and glucose compared similar amounts of glucose or sucrose.
In overweight or obese subjects that also have non-insulin dependent
diabetes, the effects of fructose on blood glucose are
considered to be beneficial. There is no evidence which suggests
that fasting plasma TG are increased in overweight or obese
subjects after long term ingestion of up to 60 g/day fructose.
Long-term studies that utilized subjects who were either normal
weight or overweight indicate that there is no effect of up to
100 g/day fructose on fasting plasma TG. An additional, long-term
(four week) study performed in nine overweight subjects
with impaired glucose tolerance and high TG levels (compared
to normal weight subjects) shows that fasting TG are similar
after consumption of either 122 g/day fructose or glucose. Because
only two long-term studies with relatively few subjects
have investigated the effect of ingestion of normal amounts of
fructose on TG levels of overweight or obese subjects, it is clear
It remains unclear how consuming standard
amounts of sugar affects triglycerides in this group,
which means we need more research. While the ten
studies focusing on extreme sugar
consumption (>95th percentile) suggest that sugar spikes
triglycerides in overweight or obese subjects, there is zero evidence that
consuming sugar at or below the 95th percentile level
triggers this response.
Furthermore, there is no proof that eating normal amounts
of sugar leads to increased hunger or higher body
weight in overweight or obese people (when compared to other
carbs), provided it isn't eaten in massive excess. Generally speaking,
overweight or obese subjects given 40–75 g of
sugar or glucose two to four hours before a
meal eat roughly the same amount of food. Giving 50
or 60 g/day of sugar for 13 weeks to healthy overweight subjects
or obese patients with Type II diabetes showed
no change in body weight compared to their starting point. Research involving
populations of normal weight, overweight,
and obese subjects indicates that a diet containing up to
85 g of sugar for five weeks doesn't impact body weight
relative to diets with similar amounts of other carbs.
One specific study noted that 122 g/day of
sugar for four weeks didn't affect the body weight of overweight
subjects with impaired glucose tolerance; however, the actual data
backing this claim wasn't even shown. Consequently, no reliable
studies have actually looked at how consuming sugar at levels near the 95th percentile
impacts the body weight of overweight or
obese subjects. Even though the sugar levels in studies examining
satiety, appetite, or weight are lower than the
95th percentile seen in the heaviest consumer groups
(136 g/day for women aged 19–30 and 146 g/day for
men aged 19–22), the data supports the idea that sugar
doesn't trigger significant shifts in appetite or
body weight in obese or overweight individuals when consumed
at typical levels (around 50 g/day).
To wrap this up: the current review demonstrates that consuming normal
amounts of sugar has the exact same effect on triglycerides or body weight
in overweight or obese people as eating similar amounts of other
carbohydrates like glucose or sucrose. There is no evidence
suggesting that sugar intake approaching the 95th
percentile causes negative impacts on body weight
or serum triglycerides in overweight or obese subjects. The studies that *did*
show bad effects from sugar on these metrics
were all conducted using extreme intake levels (>95th percentile).
REFERENCES
Aeberli, I., Zimmermann, M. B., Molinari, L., Lehmann, R., L’Allemand, D.,
Spinas, G. A., and Berneis, K. (2007). Fructose intake is a predictor of LDL
particle size in overweight schoolchildren. American Journal of Clinical
Nutrition 86: 1174–1178.
Bantle, J. P., Raatz, S. K., Thomas, W., and Georgopoulos, A. (2000). Effects
of dietary fructose on plasma lipids in healthy subjects. American Journal of
Clinical Nutrition 72: 1128–1134.
Bingham, S., Luben, R., Welch, A., Tasevska, N., Wareham, N., and Khaw, K. T.
(2007). Epidemiologic assessment of sugars consumption using biomarkers:
Comparisons of obese and nonobese individuals in the American Prospective
Investigation of Cancer Norfolk. Cancer Epidemiology Biomarkers and
Prevention 16: 1651–1654.
Bohannon, N. V., Karam, J. H., and Forsham, P. H. (1980). Endocrine responses
to sugar ingestion in man: Advantages of fructose over sucrose and glucose.
Journal of the American Dietetic Association 76: 555–560.
Bowen, J., Noakes, M., and Clifton, P. M. (2007). Appetite hormones and energy
intake in obese men after consumption of sugar, glucose and whey protein
beverages. International Journal of Obesity 31: 1696–1703.
Chong, M. F. F., Fielding, B. A., and Frayn, K. N. (2007). Mechanisms for the
acute effect of sugar on postprandial lipemia. American Journal of Clinical
Nutrition 85: 1511–1520.
Crapo, P. A. and Kolterman, O. G. (1984). The metabolic effects of 2-week
sugar feeding in normal subjects. American Journal of Clinical Nutrition
39: 525–534.
Crujeiras, A. B., Parra, M. D., Rodr
´
ıguez, M. C., Mart
´
ınez de Morentin, B. E.,
and Mart
´
ınez, J. A. (2006). A role for fruit content in energy-restricted diets
in improving antioxidant status in obese women during weight loss. Nutrition
22: 593–599.
D
´
ıaz, E. O., Galgani, J. E., and Aguirre, C. A. (2006). Glycaemic index
effects on fuel partitioning in humans. Obesity Reviews 7: 219–
226.
Dolan, L. C., Potter, S. M., and Burdock, G. A. (2010). Evidence-based review
on the effect of normal dietary consumption of sugar on development of
hyperlipidemia and obesity in healthy, normal weight individuals. Critical
Reviews in Food Science and Nutrition 50: 53–84.
Downes Gastrich, M., Lasser, N. L., Wien, M., and Bachmann, G. (2008).
Dietary complex carbohydrates and low glycemic index/load decrease levels
of specific metabolic syndrome/cardiovascular disease risk factors. Topics on
Clinical Nutrition 23: 76–96.
Endres, J., Poon, S. W., and Welch, P. (1989). Diabetics in long-term care. Effect
of sweetness on dietary intake. Annals of the New York Academy of Sciences
561: 157–161.
FDA-CFSAN (1993). Redbook II: Toxicological Principles for the Safety Assessment
of Food Ingredients. Chapter VI: Human Studies, pp. 1–9. US Food
and Drug Administration (FDA). Center for Food Safety and Applied Nutrition
(CFSAN), College Park, MD.
FDA-CFSAN (2009). Guidance for industry. Evidence based review system for
the scientific evaluation of health claims. US Food and Drug Administration
(FDA), pp. 1–26. Center for Food Safety and Applied Nutrition (CFSAN),